SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?

The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to government interventions.
|
||||||
💡 newsR Knowledge: Other News Mentions
|
![]()
China ‘NOT AFRAID’ Of Trump’s 245% Tariffs | Trade War Erupts Over Boeing Deal, Blackmail Claims
Credit: Oneindia Duration: 03:36Published
|
![]()
BREAKING: Ukraine Confirms Loss of Another U.S.-made F-16 Fighting Falcon During Combat Operations
Credit: Oneindia Duration: 03:19Published
|
![]()
‘Pay Tariffs or Stop Doing Business with Us’: Trump Dares Nations, Shrugs Off Market Crash | Details
Credit: Oneindia Duration: 03:30Published
|